The generic pharmaceutical industry: moving beyond incremental innovation towards re-innovation Journal title: Generics and Biosimilars Initiative Journal Authors: Fereshteh Barei, Claude Le Pen, Steven Simoens Subject(s):
The ‘Ginger-Biomedicines’ Act as ‘Preventive-Natural-Gifts’ against ‘Omicron-Deltacron-Rupacron-Futuracron-Like-any- New-Variants Journal title: Advances in Clinical Toxicology Authors: Datta SC* Subject(s): Toxicology
